Blog

Gout incidence down with SGLT2 inhibitors in type 2 diabetes

Adults with type 2 diabetes newly prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor have a lower incidence of gout than those prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a study published online Jan. 14 in the Annals of Internal Medicine. » Read more Source: Medical Xpress

Flu shots help prevent illness, death in heart disease patients

An annual flu vaccination is inexpensive, easy and proven to prevent illness and death in people with heart disease, however, almost 1 in 3 patients skip the flu shot, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2019—November 16-18 in Philadelphia. » Read more Source: Medical Xpress

Recovering from metabolic syndrome significantly reduces risk for cardiovascular disease

It is known that metabolic syndrome (high blood pressure, high blood sugar, excess abdominal fat, high triglyceride level, and/or unhealthy cholesterol levels) is associated with an increased risk of cardiovascular disease. » Read more Source: Medical Xpress

Long-Term Marijuana Use May Raise Men’s Testicular Cancer Risk

A new review of studies conducted over more than four decades points to an association between long-term marijuana use and testicular cancer, although evidence of that connection is not definitive proof. » Read more Source: CURE

Adding weight loss counseling to group visits improves diabetes outcomes

For people with difficult-to-control diabetes, adding intensive weight management counseling to group medical visits provided extra health benefits beyond improved blood-sugar control, according to a study led by researchers at the Duke Diet & Fitness Center and the Department of Veterans Affairs. » Read more Source: Medical Xpress

Researchers identify a process responsible for therapeutic resistance in breast cancer

Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. This holds the promise of opening the door to new therapies for overcoming drug resistance. » Read more Source: Medical Xpress

Investigational drugs reduce risk of death from Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo (DRC). » Read more Source: Medical Xpress

New weapon in fight against lethal fungi

Researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters. » Read more Source: Science Daily

Drug can extend survival rates for heart failure patients

Blood pressure medication can prevent fluid retention and muscle wasting in heart failure. » Read more Source: Science Daily

Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers

A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study has shown. » Read more Source: Science Daily